Methods and compositions involved in cell growth, neoplasia and

Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530350, C12N 1500, C07K 1400

Patent

active

056984278

ABSTRACT:
A peptide, Hel-N1, which can bind to a 3'-untranslated mRNA sequence (which encompasses the "instability sequence") that is uniquely present in the messenger RNAs that encode oncoproteins and lymphokines, and mediates the specific destruction of the messenger RNAs, is described. Full-length Hel-N1 is capable of suppressing cell growth and causing cellular differentiation. Hel-N1 possess three RNA recognition motifs. One of these forms an RNA-binding domain which, when transfected alone into cells, causes them to undergo rapid growth.

REFERENCES:
Malter et al Science 246: 664, 1989.
Meijlink et al PNAS 82: 4987, 1985.
Shaw et al Cell 48: 659, 1986.
Mashall Science 270: 1751, 1995.
Coughlan New Scientist, 25 Nov. 1995 pp. 14-15.
Donahue et al JEM 176: 1125, 1992.
Orkin & Motulsky "Report & Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy", Dec. 7, 1995.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions involved in cell growth, neoplasia and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions involved in cell growth, neoplasia and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions involved in cell growth, neoplasia and will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-205006

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.